October 2007 Issue of MMM
To say that tackling patient compliance and persistence poses a challenge to the pharmaceutical industry is like calling Tiger Woods a competent golfer or describing ...
Big pharma has long looked to biotechs to help fatten pipelines, but one company has experienced the benefits of keeping things in-house. Matthew Arnold looks ...
Several distinguished experts from pharmaceutical marketing and media descend on the offices of MM&M to discuss the evolution, effectiveness and measurement of point-of-care communications. James ...
AstraZeneca's Arimidex Web site features the innovative use of social media wherein patients actually become part of the product marketing while simultaneously forging a relationship ...
Medical/surgical journals ad spend declines by 5% and continues on its downward trend. PERQ/HCI's Eugene M. May reports on the numbers for the first half ...
Frank Burroughs is the soul of patience—and persistence.
I've heard a lot of chatter recently about whether pharma companies are spending less on marketing research than in previous years.
I never believed it was entirely fair that Eli Lilly was the target of vicious attacks regarding its anti-psychotic drug, Zyprexa.
In a medical-education ruling expected to have broad consequences, regulators said they will consider advertising agencies and journal publishers as commercial entities, requiring those that ...
Med Ed Report
As John Connolly settles into his new post as president & CEO of M|C Communications, he may find certain experiences from his past especially useful.
CME advocates will take a targeted set of talking points with them this fall to meetings with representatives on Capitol Hill.
Private equity firm Alta Communications bought HMP Communications from BG Media Investors.
Sens. Chuck Grassley (R-IA) and Herb Kohl (D-WI) introduced legislation that would require drug and device manufacturers to disclose to HHS anything of value given ...
Kevin Heffernan was promoted to the position of director, American Medical Association accreditation and CPPD educational activities.
Elsevier is upping the ante for online medical publishing with an advertising-supported Web site for physicians using content from most of its more than 100 ...
The Journal of the American Medical Association reclaimed its place as the top medical/surgical journal by ad revenue.
The British Medical Journal poached Nature Publishing Group's Peter Ashman to serve as its publishing director.
Nature Publishing Group says its cardiovascular specialty title will now accept original research.
Canon Communications, a subsidiary of Apprise Media, acquired Med Ad News and PharmaLive publisher Engel Publishing Partners from Euromoney Institutional Investor.
Advanstar's Urology Times won two Azbee Awards from the American Society of Business Publication Editors.
With annual approvals for NMEs at their lowest point in a decade, one would think pharma would launch fewer ad campaigns.
Internet advertising revenues reached a new high of $4.9 million in the first quarter of 2007.
Marketers from Novartis Vaccines and Diagnostics have jumped into the user-generated content arena with a contest that invites Web-savvy filmmakers to submit their work and ...
Women are more likely than men to search the Web for health information, according to a survey conducted by researchers from Smithfield, RI's Bryant University.
Wunderman has hired Ira Haimowitz for the newly created role of group director, datastrategy.
UK drugmaker GlaxoSmithKline is eyeing cuts to its sales force in response to declining sales of its type 2 diabetes drug Avandia.
Salix Pharmaceuticals and Eisai have entered into a multi-year co-promotion deal to promote Salix's ulcerative colitis treatement Colazal (balsalazide disodium).
Mary Ann Kim has joined MediZine as senior marketing manager, brand services from AWE, an entertainment marketing agency under Omnicom, where she was responsible for ...
The Center for Business Intelligence will host the Pharmaceutical Direct to Physician Sales and Marketing Summit on Oct. 24-25 to discuss how marketers can leverage ...
HealthEd has hired Jennifer Kirchherr as senior account executive, supporting interactive media development of tailored patient education programs.
Dudnyk was certified by Proscape Technologies to implement its Closed Loop Marketing software for tablet PC-based programs.
The FDA is planning to launch a study into whether positive, upbeat or relaxing images appearing in DTC TV ads may also distract viewers from ...
Myriad Genetics, a Salt Lake City diagnostics firm which offers testing for genetic susceptibility to breast and ovarian cancer, is launching a northeast regional advertising ...
TNS Media Intelligence/Cymfony released a white paper on social media monitoring and marketing designed to help companies delve into social media like blogs, podcasts, social ...
In a critical Aug. 16 article on the impact of DTC advertising, The New England Journal of Medicine reported that spending on DTC pharmaceutical advertising ...
Liberal think tank the Center for American Progress called for the restoration of the pre-1985 moratorium on DTC advertising to require the same disclosures of ...
Prescription Access Litigation project director Alex Sugarman-Brozan told the Third Annual FDA Regulatory Symposium at Harvard in August that the agency is neglecting to enforce ...
The word transparency resonates with communications professionals, accountants, auditors and marketers alike.
With advocacy groups pouring millions into advertising and PR aimed at influencing the national debate on health insurance, it must be a presidential election cycle.
Ketchum reorganized its London management, naming former European healthcare head Avril Lee as co-deputy CEO, responsible for the office's three main consultancy offers in healthcare, ...
Having trouble comparing blogs, text messages or word-of-mouth to other forms of communication modes in terms of how they influence your brand?
Three firms are challenging Maine and Vermont over new state laws that restrict the collection and disclosure of physician prescribing information.
Many were waiting to see if and when the new FDA commissioner would make a significant difference in the agency's defensive, stonewalling posture.
Data from the US Military Health System related to the review and use of FDA-regulated drugs, biologics and medical devices will be shared with the ...
The Washington, DC Court of Appeals has ruled in the FDA's favor that terminally ill patients have no "fundamental right 'deeply rooted in this nation's ...
Abbott employees have edited over 1,000 online Wikipedia entries involving some of the company's drug products in an attempt to change or remove unfavorable safety ...
A 10-year review of DTC advertising by researchers from three major universities suggests that oversight of advertising by the FDA’s DDMAC has declined dramatically.
The FDA says a professional journal ad for Pfizer's antipsychotic medication Geodon (ziprasidone mesylate) for injection omits important risk info and contains unsubstantiated superiority claims.
A professional file card for Novartis' Exelon makes unsubstantiated superiority claims, overstates the drug's efficacy.
The FDA reports that Bristol-Myers Squibb has revised hepatitis B therapy Baraclude's boxed warning labeling to caution against its use in HIV/hepatitis B virus co-infected ...
A GlaxoSmithKline supplemental NDA for a stronger version of asthma drug Advair Diskus for use in treating patients with chronic obstructive pulmonary disease, recommended for ...
In baseball, a pitch that was perfect in Abner Doubleday's era would still be pretty darn good today--the dimensions of the strike zone have stayed ...
- Sunovion hires former BI exec as VP of marketing
- Five things for pharma marketers to know: Thursday, October 20, 2016
- Five things for pharma marketers to know: Wednesday, October 19, 2016
- Five things for pharma marketers to know: Monday, October 24, 2016
- Five things for pharma marketers to know: Tuesday, October 25, 2016
- Merck educates doctors about biosimilars, long before it will sell one in the U.S.
- 4 trends with the potential to change behavior in the patient journey
- 2016 Pharma Report: All the data in one place
- What do physicians think about biosimilars?
- Novartis considers new sales model for experimental cancer therapy